Hycamtin Interactions
There are 426 drugs known to interact with Hycamtin (topotecan), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 51 are major, 359 are moderate, and 16 are minor.
- View all 426 medications that may interact with Hycamtin
- View Hycamtin alcohol/food interactions (1)
- View Hycamtin disease interactions (6)
Most frequently checked interactions
View interaction reports for Hycamtin (topotecan) and the medicines listed below.
- Actemra (tocilizumab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Afinitor (everolimus)
- Aubagio (teriflunomide)
- Avastin (bevacizumab)
- Betaseron (interferon beta-1b)
- bleomycin
- Bosulif (bosutinib)
- Camptosar (irinotecan)
- carboplatin
- Cayston (aztreonam)
- cisplatin
- Copaxone (glatiramer)
- Coreg (carvedilol)
- Cosentyx (secukinumab)
- Cytoxan (cyclophosphamide)
- Cytoxan Lyophilized (cyclophosphamide)
- dexamethasone
- doxorubicin
- Dupixent (dupilumab)
- Fludara (fludarabine)
- Lasix (furosemide)
- Leukeran (chlorambucil)
- Neulasta (pegfilgrastim)
- Neupogen (filgrastim)
- Nexavar (sorafenib)
- Oncovin (vincristine)
- Taxotere (docetaxel)
Hycamtin alcohol/food interactions
There is 1 alcohol/food interaction with Hycamtin (topotecan).
Hycamtin disease interactions
There are 6 disease interactions with Hycamtin (topotecan) which include:
Report options
QR code containing a link to this page
More about Hycamtin (topotecan)
- Hycamtin consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
